TGFβ1 treatment in breast cancer cells triggers active CDK5/p35 to phosphorylate Focal Adhesion Kinase (FAK) at S732, causing metastatic invasion and EMT by potentiating F-actin bundle formation [42] (Fig. 1A). This evidence concerns the gene CDK5 and breast cancer.